Consolidated Statements of Earnings - USD ($) shares in Millions, $ in Millions	3 Months Ended		6 Months Ended
	Jun. 28, 2026	Jun. 29, 2025	Jun. 28, 2026	Jun. 29, 2025
Income Statement [Abstract]
Sales to customers (Note 9)	$ 25,310	$ 23,743	$ 49,372	$ 45,636
Sales to customers percent to sales	100.00%	100.00%	100.00%	100.00%
Cost of products sold	$ 8,051	$ 7,628	$ 16,157	$ 14,985
Cost of products sold percent to sales	31.80%	32.10%	32.70%	32.80%
Gross profit	$ 17,259	$ 16,115	$ 33,215	$ 30,651
Gross Profit Percent To Sales	68.20%	67.90%	67.30%	67.20%
Selling, marketing and administrative expenses	$ 6,432	$ 5,889	$ 12,466	$ 11,001
Selling marketing and administrative expenses percent to sales	25.40%	24.80%	25.30%	24.10%
Research and development expense	$ 3,653	$ 3,516	$ 7,180	$ 6,741
Research and development expense percent to sales	14.40%	14.80%	14.50%	14.80%
In-process research and development impairments			$ 36	$ 0
In-process research and development percent to sales			0.10%	0.00%
Interest income	$ (219)	$ (260)	$ (448)	$ (592)
Interest income percent to sales	(0.90%)	(1.10%)	(0.90%)	(1.30%)
Interest expense, net of portion capitalized	$ 281	$ 308	$ 553	$ 512
Interest expense, net of portion capitalized percent to sales	1.10%	1.30%	1.10%	1.10%
Other (income) expense, net	$ 331	$ 107	$ 625	$ (7,214)
Other (income) expense, net percent to sales	1.30%	0.50%	1.30%	(15.80%)
Restructuring (Note 12)	$ 34	$ 64	$ 66	$ 81
Restructuring charge percent to sales	0.20%	0.30%	0.10%	0.20%
Earnings before provision for taxes on income	$ 6,747	$ 6,491	$ 12,737	$ 20,122
Earnings before provision for taxes on income percent to sales	26.70%	27.30%	25.80%	44.10%
Provision for taxes on income (Note 5)	$ 1,213	$ 954	$ 1,968	$ 3,586
Provision for taxes on income percent to sales	4.80%	4.00%	4.00%	7.90%
Net earnings from continuing operations percent of sales	21.90%	23.30%	21.80%	36.20%
Net earnings	$ 5,534	$ 5,537	$ 10,769	$ 16,536
NET EARNINGS PER SHARE
Total net earnings per share - basic (in dollars per share)	$ 2.30	$ 2.30	$ 4.47	$ 6.87
Total net earnings per share - diluted (in dollars per share)	$ 2.27	$ 2.29	$ 4.41	$ 6.82
Avg. shares outstanding
Basic (shares)	2,407.4	2,406.3	2,408.1	2,406.7
Diluted (shares)	2,440.1	2,419.1	2,443.9	2,423.3

Consolidated Statements of Cash Flows - USD ($) $ in Millions	6 Months Ended
	Jun. 28, 2026	Jun. 29, 2025
CASH FLOWS FROM OPERATING ACTIVITIES
Net earnings	$ 10,769	$ 16,536
Adjustments to reconcile net earnings to cash flows from operating activities:
Depreciation and amortization of property and intangibles	3,963	3,715
Stock based compensation	758	698
Asset write-downs	220	30
Charges for acquired in-process research and development assets	2	92
Net loss/(gain) on sale of assets/businesses	(43)	(74)
Deferred tax provision	(320)	2,997
Credit losses and accounts receivable allowances	(12)	3
Changes in assets and liabilities, net of effects from acquisitions and divestitures:
Increase in accounts receivable	(1,947)	(2,283)
Increase in inventories	(1,002)	(656)
Decrease in accounts payable and accrued liabilities	(956)	(886)
Decrease/(Increase) in other current and non-current assets	1,299	(6,194)
Decrease in other current and non-current liabilities	(1,601)	(5,926)
Net cash flows from operating activities	11,130	8,052
Cash flows used for investing activities
Additions to property, plant and equipment	(2,370)	(1,838)
Proceeds from the disposal of assets/businesses, net (Note 10)	92	332
Acquisitions, net of cash acquired (Note 10)	(263)	(14,458)
Acquired in-process research and development assets / related milestones (Note 10)	0	(369)
Purchases of investments	(299)	(431)
Sales of investments	368	953
Credit support agreements activity, net	515	(2,684)
Other (including capitalized licenses and milestones)	(193)	(66)
Net cash used for investing activities	(2,150)	(18,561)
Cash flows (used for) from financing activities
Dividends to shareholders	(6,358)	(6,118)
Repurchase of common stock	(4,249)	(2,127)
Proceeds from short-term debt, net	13,146	9,349
Repayment of short-term debt, net	(9,677)	(5,058)
Proceeds from long-term debt, net of issuance costs	0	9,138
Repayment of long-term debt	(2,003)	(754)
Proceeds from the exercise of stock options/employee withholding tax on stock awards, net	1,531	557
Credit support agreements activity, net	(49)	(271)
Other	(588)	41
Net cash (used for) from financing activities	(8,247)	4,757
Effect of exchange rate changes on cash and cash equivalents	(20)	224
Increase in cash and cash equivalents	713	(5,528)
Cash and cash equivalents, beginning of period	19,709	24,105
Cash and cash equivalents, end of period	$ 20,422	$ 18,577

Consolidated Balance Sheets - USD ($) $ in Millions	Jun. 28, 2026	Dec. 28, 2025
Current assets:
Cash and cash equivalents (Note 4)	$ 20,422	$ 19,709
Marketable securities	336	393
Accounts receivable, trade, less allowances $171 (2025, $183)	19,046	17,178
Inventories (Note 2)	15,144	14,191
Prepaid expenses and other	4,826	4,153
Total current assets	59,774	55,624
Property, plant and equipment at cost	55,518	54,364
Less: accumulated depreciation	(31,936)	(31,195)
Property, plant and equipment, net	23,582	23,169
Intangible assets, net (Note 3)	48,229	50,403
Goodwill (Note 3)	48,479	48,772
Deferred taxes on income (Note 5)	6,728	6,874
Other assets	14,269	14,368
Total assets	201,061	199,210
Current liabilities:
Loans and notes payable	11,692	8,495
Accounts payable	9,223	11,991
Accrued liabilities	9,464	8,594
Accrued rebates, returns and promotions	19,990	19,124
Accrued compensation and employee related obligations	3,475	4,534
Accrued taxes on income (Note 5)	1,051	1,388
Total current liabilities	54,895	54,126
Long-term debt (Note 4)	37,344	39,438
Deferred taxes on income (Note 5)	6,608	6,791
Employee related obligations (Note 6)	6,657	6,957
Long-term taxes payable (Note 5)	485	486
Other liabilities	10,101	9,868
Total liabilities	116,090	117,666
Commitments and Contingencies (Note 11)
Shareholders’ equity:
Common stock — par value $1.00 per share (authorized 4,320,000,000 shares; issued 3,119,843,000 shares)	3,120	3,120
Accumulated other comprehensive income (loss) (Note 7)	(13,951)	(14,930)
Retained earnings and Additional paid-in capital	171,665	168,978
Less: common stock held in treasury, at cost (711,615,000 and 711,904,000 shares)	75,863	75,624
Total shareholders’ equity	84,971	81,544
Total shareholders’ equity	84,971	81,544
Total liabilities and shareholders’ equity	$ 201,061	$ 199,210